$1.63
-0.04-2.40%
Pre-Market: 4:03 PM EDT
Comments
Loading...
Latest Aclaris Therapeutics Stock News | NASDAQ:ACRS | Benzinga
Get the latest news on Aclaris Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Aclaris Therapeutics performance
Categories: All
Tuesday, March 18, 2025
Friday, March 07, 2025
Thursday, February 27, 2025
Wednesday, February 12, 2025
Monday, December 23, 2024
Tuesday, November 19, 2024
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments
- This BioNTech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- Leerink Partners Upgrades Aclaris Therapeutic...
- Jefferies Upgrades Aclaris Therapeutics to Bu...
- Aclaris Therapeutics shares are trading highe...
- BTIG Upgrades Aclaris Therapeutics to Buy, An...
Monday, November 18, 2024
Wednesday, November 06, 2024
Monday, October 28, 2024
Friday, October 25, 2024
Tuesday, September 17, 2024
Monday, August 19, 2024
Wednesday, August 07, 2024
Tuesday, July 23, 2024
Monday, July 22, 2024
Tuesday, July 16, 2024
Tuesday, July 09, 2024
Monday, July 08, 2024
Friday, June 14, 2024
Friday, May 24, 2024
Tuesday, May 07, 2024
Monday, May 06, 2024
Wednesday, March 06, 2024
Tuesday, February 27, 2024
Monday, January 22, 2024
- Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
- Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
- HC Wainwright & Co. Downgrades Aclaris Therap...